Drybench Patent.

Patent and exclusivity dates from July to December 2033 for NDAs, as FDA's Orange Book lists them

Each patent and exclusivity date from July to December 2033 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured: 14 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed dates, 2033 January to June 2033

Listed patent expiry (299)

1 Jul 2033 · NDA 208313 · GEMCITABINE HYDROCHLORIDE
US 9,241,948, product patent
patent.txt lines 8,449–8,458
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007, 008, 009, 010
1 Jul 2033 · NDA 208603 · MORPHINE SULFATE
US 9,044,402, product and use patent
patent.txt lines 8,902, 8,904, 8,906
Flags
product use code U-1556
Product numbers
001, 002, 003
1 Jul 2033 · NDA 208603 · MORPHINE SULFATE
US 9,549,899, product and use patent
patent.txt lines 8,903, 8,905, 8,907
Flags
product use code U-1556
Product numbers
001, 002, 003
2 Jul 2033 · NDA 213176 · UMBRALISIB TOSYLATE
US 10,072,013, use patent
patent.txt line 14,705
Flags
use code U-3063
Product numbers
001
2 Jul 2033 · NDA 213176 · UMBRALISIB TOSYLATE
US 10,072,013, use patent
patent.txt line 14,706
Flags
use code U-3064
Product numbers
001
2 Jul 2033 · NDA 213176 · UMBRALISIB TOSYLATE
US 10,570,142, substance and product and use patent
patent.txt line 14,709
Flags
substance product use code U-3063
Product numbers
001
2 Jul 2033 · NDA 213176 · UMBRALISIB TOSYLATE
US 10,570,142, substance and product and use patent
patent.txt line 14,710
Flags
substance product use code U-3064
Product numbers
001
2 Jul 2033 · NDA 213176 · UMBRALISIB TOSYLATE
US 10,981,919, use patent
patent.txt line 14,713
Flags
use code U-3063
Product numbers
001
2 Jul 2033 · NDA 213176 · UMBRALISIB TOSYLATE
US 10,981,919, use patent
patent.txt line 14,714
Flags
use code U-3064
Product numbers
001
2 Jul 2033 · NDA 213176 · UMBRALISIB TOSYLATE
US 9,150,579, substance and product patent
patent.txt line 14,715
Flags
substance product
Product numbers
001
2 Jul 2033 · NDA 213176 · UMBRALISIB TOSYLATE
US 9,669,033, use patent
patent.txt line 14,716
Flags
use code U-3063
Product numbers
001
2 Jul 2033 · NDA 213176 · UMBRALISIB TOSYLATE
US 9,669,033, use patent
patent.txt line 14,717
Flags
use code U-3064
Product numbers
001
2 Jul 2033 · NDA 213227 · COPPER CU-64 DOTATATE
US 10,383,961, use patent
patent.txt line 14,811
Flags
use code U-2951
Product numbers
001
3 Jul 2033 · NDA 212306 · SELINEXOR
US 8,999,996, substance and product patent
patent.txt lines 13,847, 13,866, 13,885, 13,904, 13,923, 13,942
Flags
substance product
Product numbers
001, 002, 003, 004, 005, 006
9 Jul 2033 · NDA 208692 · CABOZANTINIB S-MALATE
US 9,724,342, product patent
patent.txt lines 9,196, 9,216, 9,236
Flags
product
Product numbers
001, 002, 003
15 Jul 2033 · NDA 210491 · IVACAFTOR; IVACAFTOR, TEZACAFTOR
US 10,058,546, use patent
patent.txt lines 11,416, 11,449
Flags
use code U-3022
Product numbers
001, 002
15 Jul 2033 · NDA 210491 · IVACAFTOR; IVACAFTOR, TEZACAFTOR
US 10,058,546, use patent
patent.txt lines 11,417, 11,450
Flags
use code U-3023
Product numbers
001, 002
15 Jul 2033 · NDA 210491 · IVACAFTOR; IVACAFTOR, TEZACAFTOR
US 9,012,496, use patent
patent.txt lines 11,440, 11,472
Flags
use code U-2248
Product numbers
001, 002
15 Jul 2033 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 9,012,496, use patent
patent.txt line 13,716
Flags
use code U-2649
Product numbers
001
15 Jul 2033 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 9,012,496, use patent
patent.txt lines 13,717, 13,784
Flags
use code U-3154
Product numbers
001, 002
15 Jul 2033 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US 10,058,546, use patent
patent.txt line 21,229
Flags
use code U-4218
Product numbers
002
15 Jul 2033 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US 9,012,496, use patent
patent.txt line 21,266
Flags
use code U-4097
Product numbers
002
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 10,028,946, use patent
patent.txt lines 3,422, 3,438, 3,454, 3,470, 3,486, 3,502
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 10,322,120, product patent
patent.txt lines 3,424, 3,440, 3,456, 3,472, 3,488, 3,504
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 10,456,393, use patent
patent.txt lines 3,425, 3,441, 3,457, 3,473, 3,489, 3,505
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 10,722,511, use patent
patent.txt lines 3,426, 3,442, 3,458, 3,474, 3,490, 3,506
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,265,760, use patent
patent.txt lines 3,428, 3,444, 3,460, 3,476, 3,492, 3,508
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,326,982, use patent
patent.txt lines 3,429, 3,445, 3,461, 3,477, 3,493, 3,509
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,333,201, use patent
patent.txt lines 3,430, 3,446, 3,462, 3,478, 3,494, 3,510
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,339,499, use patent
patent.txt lines 3,431, 3,447, 3,463, 3,479, 3,495, 3,511
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,421,200, use patent
patent.txt lines 3,432, 3,448, 3,464, 3,480, 3,496, 3,512
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,433,619, use patent
patent.txt lines 3,433, 3,449, 3,465, 3,481, 3,497, 3,513
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,610,286, use patent
patent.txt lines 3,436, 3,452, 3,468, 3,484, 3,500, 3,516
Flags
use code U-1810
Product numbers
001, 002, 003, 004, 005, 006
25 Jul 2033 · NDA 208073 · LIFITEGRAST
US 9,085,553, product patent
patent.txt line 8,090
Flags
product
Product numbers
001
25 Jul 2033 · NDA 212268 · ASENAPINE
US 10,022,445, product patent
patent.txt lines 13,626, 13,632, 13,638
Flags
product
Product numbers
001, 002, 003
25 Jul 2033 · NDA 212268 · ASENAPINE
US 10,583,121, product and use patent
patent.txt lines 13,627, 13,633, 13,639
Flags
product use code U-2763
Product numbers
001, 002, 003
25 Jul 2033 · NDA 212268 · ASENAPINE
US 10,814,002, product and use patent
patent.txt lines 13,628, 13,634, 13,640
Flags
product use code U-2763
Product numbers
001, 002, 003
25 Jul 2033 · NDA 212268 · ASENAPINE
US 11,123,305, product patent
patent.txt lines 13,629, 13,635, 13,641
Flags
product
Product numbers
001, 002, 003
25 Jul 2033 · NDA 212268 · ASENAPINE
US 9,687,474, product patent
patent.txt lines 13,631, 13,637, 13,643
Flags
product
Product numbers
001, 002, 003
1 Aug 2033 · NDA 211801 · TENAPANOR HYDROCHLORIDE
US 8,541,448, substance and product patent
patent.txt line 13,185
Flags
substance product
Product numbers
001
1 Aug 2033 · NDA 213931 · TENAPANOR HYDROCHLORIDE
US 8,541,448, substance and product patent
patent.txt lines 15,309, 15,317, 15,325
Flags
substance product
Product numbers
001, 002, 003
2 Aug 2033 · NDA 215014 · PEGCETACOPLAN
US 10,125,171, substance patent
patent.txt line 16,418
Flags
substance
Product numbers
001
2 Aug 2033 · NDA 217171 · PEGCETACOPLAN
US 10,125,171, substance patent
patent.txt line 19,274
Flags
substance
Product numbers
001
5 Aug 2033 · NDA 210496 · ENCORAFENIB
US 9,474,754, use patent
patent.txt line 11,536
Flags
use code U-2802
Product numbers
002
5 Aug 2033 · NDA 210496 · ENCORAFENIB
US 9,474,754, use patent
patent.txt line 11,537
Flags
use code U-4051
Product numbers
002
5 Aug 2033 · NDA 210496 · ENCORAFENIB
US 9,474,754, use patent
patent.txt line 11,538
Flags
use code U-4440
Product numbers
002
7 Aug 2033 · NDA 211448 · ARIPIPRAZOLE
US 9,694,008, product patent
patent.txt lines 12,871–12,873
Flags
product
Product numbers
001, 002, 003
8 Aug 2033 · NDA 221075 · IBERDOMIDE HYDROCHLORIDE
US 9,629,849, use patent
patent.txt lines 22,409, 22,416
Flags
use code U-4598
Product numbers
001, 002
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 10,857,143, product and use patent
patent.txt lines 7,836, 7,846, 7,856
Flags
product use code U-2993
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 11,103,494, product patent
patent.txt lines 7,837, 7,847, 7,857
Flags
product
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 11,103,495, product and use patent
patent.txt lines 7,838, 7,848, 7,858
Flags
product use code U-2993
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 11,633,389, product patent
patent.txt lines 7,839, 7,849, 7,859
Flags
product
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 8,999,386, product patent
patent.txt lines 7,842, 7,852, 7,862
Flags
product
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 9,295,642, product and use patent
patent.txt lines 7,843, 7,853, 7,863
Flags
product use code U-1827
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 9,545,399, product and use patent
patent.txt lines 7,844, 7,854, 7,864
Flags
product use code U-1827
Product numbers
001, 002, 003
14 Aug 2033 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 9,844,544, product and use patent
patent.txt lines 7,845, 7,855, 7,865
Flags
product use code U-2203
Product numbers
001, 002, 003
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt line 3,346
Flags
product use code U-4345
Product numbers
001
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt lines 3,344, 3,358
Flags
product use code U-1515
Product numbers
001, 002
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt lines 3,345, 3,374
Flags
product use code U-1516
Product numbers
001, 003
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt line 3,375
Flags
product use code U-3644
Product numbers
003
16 Aug 2033 · NDA 202811 · LINACLOTIDE
US 9,708,371, product and use patent
patent.txt line 3,376
Flags
product use code U-4566
Product numbers
003
16 Aug 2033 · NDA 211675 · UPADACITINIB
US RE47221, substance patent
patent.txt lines 13,024, 13,049, 13,068
Flags
substance
Product numbers
001, 002, 003
16 Aug 2033 · NDA 218347 · UPADACITINIB
US RE47221, substance patent
patent.txt line 20,979
Flags
substance
Product numbers
001
18 Aug 2033 · NDA 205552 · IBRUTINIB
US 9,540,382, use patent
patent.txt line 5,551
Flags
use code U-1684
Product numbers
001
18 Aug 2033 · NDA 205552 · IBRUTINIB
US 9,540,382, use patent
patent.txt lines 5,550, 5,649
Flags
use code U-1650
Product numbers
001, 002
18 Aug 2033 · NDA 205552 · IBRUTINIB
US 9,540,382, use patent
patent.txt lines 5,552, 5,650
Flags
use code U-1946
Product numbers
001, 002
18 Aug 2033 · NDA 205552 · IBRUTINIB
US 9,540,382, use patent
patent.txt line 5,648
Flags
use code U-1491
Product numbers
002
19 Aug 2033 · NDA 209500 · LUMATEPERONE TOSYLATE
US RE48839, use patent
patent.txt lines 10,467, 10,498, 10,528
Flags
use code U-3271
Product numbers
001, 002, 003
19 Aug 2033 · NDA 209500 · LUMATEPERONE TOSYLATE
US RE48839, use patent
patent.txt lines 10,468, 10,499, 10,529
Flags
use code U-4344
Product numbers
001, 002, 003
19 Aug 2033 · NDA 209500 · LUMATEPERONE TOSYLATE
US RE48839, use patent
patent.txt lines 10,469, 10,500, 10,530
Flags
use code U-814
Product numbers
001, 002, 003
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,525
Flags
substance product use code U-2350
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,526
Flags
substance product use code U-2533
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,527
Flags
substance product use code U-2534
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,528
Flags
substance product use code U-3213
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,529
Flags
substance product use code U-3386
Product numbers
001
19 Aug 2033 · NDA 211192 · IVOSIDENIB
US 9,474,779, substance and product and use patent
patent.txt line 12,530
Flags
substance product use code U-3742
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 8,927,607, use patent
patent.txt line 5,052
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 9,399,036, use patent
patent.txt line 5,053
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 9,555,029, use patent
patent.txt line 5,054
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 9,675,613, use patent
patent.txt line 5,055
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 204820 · COLCHICINE
US 9,789,108, use patent
patent.txt line 5,056
Flags
use code U-1020
Product numbers
001
22 Aug 2033 · NDA 207620 · SACUBITRIL; VALSARTAN
US 11,135,192, use patent
patent.txt lines 7,376, 7,384, 7,392
Flags
use code U-3084
Product numbers
001, 002, 003
22 Aug 2033 · NDA 207620 · SACUBITRIL; VALSARTAN
US 9,517,226, use patent
patent.txt lines 7,381, 7,389, 7,397
Flags
use code U-3084
Product numbers
001, 002, 003
22 Aug 2033 · NDA 207620 · SACUBITRIL; VALSARTAN
US 9,937,143, use patent
patent.txt lines 7,382, 7,390, 7,398
Flags
use code U-3084
Product numbers
001, 002, 003
23 Aug 2033 · NDA 210913 · CYCLOSPORINE
US 10,441,630, product patent
patent.txt line 12,389
Flags
product
Product numbers
001
23 Aug 2033 · NDA 210913 · CYCLOSPORINE
US 8,980,839, product and use patent
patent.txt line 12,392
Flags
product use code U-1483
Product numbers
001
23 Aug 2033 · NDA 210913 · CYCLOSPORINE
US 9,937,225, product and use patent
patent.txt line 12,393
Flags
product use code U-1483
Product numbers
001
26 Aug 2033 · NDA 214907 · PAFOLACIANINE SODIUM
US 10,881,747, substance and product and use patent
patent.txt line 16,319
Flags
substance product use code U-3291
Product numbers
001
26 Aug 2033 · NDA 214907 · PAFOLACIANINE SODIUM
US 9,333,270, substance and product and use patent
patent.txt line 16,322
Flags
substance product use code U-3291
Product numbers
001
26 Aug 2033 · NDA 214907 · PAFOLACIANINE SODIUM
US 9,341,629, substance and product patent
patent.txt line 16,323
Flags
substance product
Product numbers
001
26 Aug 2033 · NDA 214907 · PAFOLACIANINE SODIUM
US 9,789,208, substance and product and use patent
patent.txt line 16,324
Flags
substance product use code U-3291
Product numbers
001
26 Aug 2033 · NDA 215341 · FINERENONE
US 8,436,180, substance and product patent
patent.txt lines 16,793, 16,795, 16,797
Flags
substance product
Product numbers
001, 002, 003
30 Aug 2033 · NDA 022535 · PIRFENIDONE
US 8,778,947, use patent
patent.txt line 2,075
Flags
use code U-1613
Product numbers
001
30 Aug 2033 · NDA 202806 · DABRAFENIB MESYLATE
US 10,869,869, use patent
patent.txt lines 3,251, 3,275
Flags
use code U-3185
Product numbers
001, 002
30 Aug 2033 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 10,869,869, use patent
patent.txt lines 4,272, 4,292, 4,312
Flags
use code U-3184
Product numbers
001, 002, 003
30 Aug 2033 · NDA 208780 · PIRFENIDONE
US 8,778,947, use patent
patent.txt lines 9,368, 9,411, 9,454
Flags
use code U-2044
Product numbers
001, 002, 003
30 Aug 2033 · NDA 208780 · PIRFENIDONE
US 8,778,947, use patent
patent.txt lines 9,369, 9,412, 9,455
Flags
use code U-2045
Product numbers
001, 002, 003
2 Sep 2033 · NDA 205858 · IDELALISIB
US 9,469,643, substance patent
patent.txt lines 5,990, 5,994
Flags
substance
Product numbers
001, 002
6 Sep 2033 · NDA 204153 · LULICONAZOLE
US 9,012,484, substance and product and use patent
patent.txt line 4,334
Flags
substance product use code U-540
Product numbers
001
6 Sep 2033 · NDA 204153 · LULICONAZOLE
US 9,199,977, substance and product patent
patent.txt line 4,335
Flags
substance product
Product numbers
001
6 Sep 2033 · NDA 204153 · LULICONAZOLE
US 9,453,006, substance patent
patent.txt line 4,336
Flags
substance
Product numbers
001
6 Sep 2033 · NDA 207999 · OBETICHOLIC ACID
US 10,047,117, use patent
patent.txt lines 7,934, 7,941
Flags
use code U-1854
Product numbers
001, 002
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 10,993,942, use patent
patent.txt lines 8,861, 8,875, 8,889
Flags
use code U-3114
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 11,110,087, use patent
patent.txt lines 8,862, 8,876, 8,890
Flags
use code U-3222
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 11,110,087, use patent
patent.txt lines 8,863, 8,877, 8,891
Flags
use code U-3223
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 11,413,282, use patent
patent.txt lines 8,865, 8,879, 8,893
Flags
use code U-3412
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 11,590,128, use patent
patent.txt lines 8,866, 8,880, 8,894
Flags
use code U-3548
Product numbers
001, 002, 003
6 Sep 2033 · NDA 208573 · VENETOCLAX
US 9,539,251, use patent
patent.txt lines 8,873, 8,887, 8,901
Flags
use code U-2538
Product numbers
001, 002, 003
6 Sep 2033 · NDA 219685 · RILZABRUTINIB
US 8,940,744, substance and product and use patent
patent.txt line 21,866
Flags
substance product use code U-4270
Product numbers
001
6 Sep 2033 · NDA 219685 · RILZABRUTINIB
US 9,266,895, substance and product and use patent
patent.txt line 21,867
Flags
substance product use code U-4268
Product numbers
001
6 Sep 2033 · NDA 219685 · RILZABRUTINIB
US 9,994,576, substance and product and use patent
patent.txt line 21,869
Flags
substance product use code U-4268
Product numbers
001
6 Sep 2033 · NDA 219685 · RILZABRUTINIB
US 9,994,576, substance and product and use patent
patent.txt line 21,870
Flags
substance product use code U-4269
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 10,016,504, product patent
patent.txt line 10,276
Flags
product
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 10,918,723, use patent
patent.txt line 10,280
Flags
use code U-2310
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 12,083,179, product and use patent
patent.txt line 10,282
Flags
product use code U-2310
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 8,999,313, product patent
patent.txt line 10,283
Flags
product
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 9,326,969, use patent
patent.txt line 10,284
Flags
use code U-2310
Product numbers
001
10 Sep 2033 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 9,707,297, product patent
patent.txt line 10,286
Flags
product
Product numbers
001
11 Sep 2033 · NDA 210282 · DAPTOMYCIN
US 10,357,535, product and use patent
patent.txt lines 11,275, 11,277
Flags
product use code U-3176
Product numbers
001, 002
11 Sep 2033 · NDA 210282 · DAPTOMYCIN
US 9,655,946, product and use patent
patent.txt lines 11,276, 11,278
Flags
product use code U-3175
Product numbers
001, 002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 11,839,689, product patent
patent.txt lines 15,162, 15,177
Flags
product
Product numbers
001, 002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,447,128, use patent
patent.txt line 15,182
Flags
use code U-4312
Product numbers
002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,447,128, use patent
patent.txt line 15,183
Flags
use code U-4313
Product numbers
002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,447,128, use patent
patent.txt line 15,184
Flags
use code U-4314
Product numbers
002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,502,357, use patent
patent.txt lines 15,167, 15,185
Flags
use code U-4363
Product numbers
001, 002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,502,357, use patent
patent.txt lines 15,168, 15,186
Flags
use code U-4364
Product numbers
001, 002
11 Sep 2033 · NDA 213674 · ENZALUTAMIDE
US 12,502,357, use patent
patent.txt lines 15,169, 15,187
Flags
use code U-4365
Product numbers
001, 002
12 Sep 2033 · NDA 216675 · PERFLUOROHEXYLOCTANE
US 10,058,615, use patent
patent.txt line 18,913
Flags
use code U-1900
Product numbers
001
12 Sep 2033 · NDA 216675 · PERFLUOROHEXYLOCTANE
US 10,369,117, use patent
patent.txt line 18,914
Flags
use code U-1900
Product numbers
001
12 Sep 2033 · NDA 216675 · PERFLUOROHEXYLOCTANE
US 10,449,164, use patent
patent.txt line 18,915
Flags
use code U-1900
Product numbers
001
12 Sep 2033 · NDA 216675 · PERFLUOROHEXYLOCTANE
US 12,005,033, use patent
patent.txt line 18,919
Flags
use code U-4586
Product numbers
001
17 Sep 2033 · NDA 217785 · RESMETIROM
US 10,376,517, use patent
patent.txt lines 20,372, 20,379, 20,387
Flags
use code U-3861
Product numbers
001, 002, 003
17 Sep 2033 · NDA 217785 · RESMETIROM
US 11,564,926, substance and product and use patent
patent.txt lines 20,373, 20,380, 20,388
Flags
substance product use code U-3861
Product numbers
001, 002, 003
17 Sep 2033 · NDA 217785 · RESMETIROM
US 11,986,481, use patent
patent.txt lines 20,374, 20,381, 20,389
Flags
use code U-3861
Product numbers
001, 002, 003
17 Sep 2033 · NDA 217785 · RESMETIROM
US 9,266,861, substance and product patent
patent.txt lines 20,378, 20,386, 20,393
Flags
substance product
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 11,666,566, product patent
patent.txt lines 8,126, 8,158, 8,190
Flags
product
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,233,959, product patent
patent.txt lines 8,135, 8,167, 8,199
Flags
product
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,296,739, product patent
patent.txt lines 8,137, 8,169, 8,201
Flags
product
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,550,780, substance and product and use patent
patent.txt lines 8,139, 8,171, 8,203
Flags
substance product use code U-1995
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,550,780, substance and product and use patent
patent.txt lines 8,140, 8,172, 8,204
Flags
substance product use code U-3055
Product numbers
001, 002, 003
18 Sep 2033 · NDA 208082 · DEUTETRABENAZINE
US 9,814,708, product patent
patent.txt lines 8,142, 8,174, 8,206
Flags
product
Product numbers
001, 002, 003
18 Sep 2033 · NDA 216354 · DEUTETRABENAZINE
US 9,550,780, substance and product and use patent
patent.txt lines 18,552, 18,582, 18,612, 18,642, 18,672, 18,702, 18,732, 18,762
Flags
substance product use code U-1995
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
18 Sep 2033 · NDA 216354 · DEUTETRABENAZINE
US 9,550,780, substance and product and use patent
patent.txt lines 18,553, 18,583, 18,613, 18,643, 18,673, 18,703, 18,733, 18,763
Flags
substance product use code U-3055
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
19 Sep 2033 · NDA 207533 · ARIPIPRAZOLE LAUROXIL
US 11,097,006, product and use patent
patent.txt lines 7,278, 7,295, 7,313, 7,331
Flags
product use code U-764
Product numbers
001, 002, 003, 004
19 Sep 2033 · NDA 207533 · ARIPIPRAZOLE LAUROXIL
US 12,311,027, product and use patent
patent.txt lines 7,283, 7,300, 7,318, 7,336
Flags
product use code U-543
Product numbers
001, 002, 003, 004
20 Sep 2033 · NDA 211855 · DIROXIMEL FUMARATE
US 10,080,733, substance and product and use patent
patent.txt line 13,217
Flags
substance product use code U-1384
Product numbers
001
20 Sep 2033 · NDA 211855 · DIROXIMEL FUMARATE
US 9,090,558, use patent
patent.txt line 13,219
Flags
use code U-1384
Product numbers
001
22 Sep 2033 · NDA 212268 · ASENAPINE
US 11,813,364, product patent
patent.txt lines 13,630, 13,636, 13,642
Flags
product
Product numbers
001, 002, 003
23 Sep 2033 · NDA 210951 · APALUTAMIDE
US 10,849,888, use patent
patent.txt lines 12,434, 12,452
Flags
use code U-3013
Product numbers
001, 002
23 Sep 2033 · NDA 210951 · APALUTAMIDE
US 9,884,054, use patent
patent.txt lines 12,447, 12,465
Flags
use code U-2237
Product numbers
001, 002
23 Sep 2033 · NDA 210951 · APALUTAMIDE
US RE49353, use patent
patent.txt lines 12,449, 12,467
Flags
use code U-2381
Product numbers
001, 002
23 Sep 2033 · NDA 210951 · APALUTAMIDE
US RE50642, use patent
patent.txt lines 12,450, 12,468
Flags
use code U-4450
Product numbers
001, 002
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 10,980,803, use patent
patent.txt lines 3,523, 3,540, 3,557, 3,574
Flags
use code U-1632
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 10,980,803, use patent
patent.txt lines 3,524, 3,541, 3,558, 3,575
Flags
use code U-543
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,154,553, use patent
patent.txt lines 3,525, 3,542, 3,559, 3,576
Flags
use code U-1632
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,154,553, use patent
patent.txt lines 3,526, 3,543, 3,560, 3,577
Flags
use code U-3245
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,154,553, use patent
patent.txt lines 3,527, 3,544, 3,561, 3,578
Flags
use code U-814
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,344,547, use patent
patent.txt lines 3,528, 3,545, 3,562, 3,579
Flags
use code U-1632
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,344,547, use patent
patent.txt lines 3,529, 3,546, 3,563, 3,580
Flags
use code U-3245
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,344,547, use patent
patent.txt lines 3,530, 3,547, 3,564, 3,581
Flags
use code U-814
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,400,087, use patent
patent.txt lines 3,531, 3,548, 3,565, 3,582
Flags
use code U-1632
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,400,087, use patent
patent.txt lines 3,532, 3,549, 3,566, 3,583
Flags
use code U-3245
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 202971 · ARIPIPRAZOLE
US 11,400,087, use patent
patent.txt lines 3,533, 3,550, 3,567, 3,584
Flags
use code U-814
Product numbers
001, 002, 003, 004
24 Sep 2033 · NDA 217901 · DIHYDROERGOTAMINE MESYLATE
US 12,594,273, product patent
patent.txt line 20,770
Flags
product
Product numbers
001
25 Sep 2033 · NDA 221075 · IBERDOMIDE HYDROCHLORIDE
US 9,221,788, substance patent
patent.txt lines 22,408, 22,415
Flags
substance
Product numbers
001, 002
27 Sep 2033 · NDA 214621 · RELUGOLIX
US 11,795,178, substance and product patent
patent.txt line 15,884
Flags
substance product
Product numbers
001
27 Sep 2033 · NDA 214621 · RELUGOLIX
US 12,325,714, substance and product patent
patent.txt line 15,887
Flags
substance product
Product numbers
001
27 Sep 2033 · NDA 214846 · ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US 11,795,178, substance and product patent
patent.txt line 16,238
Flags
substance product
Product numbers
001
27 Sep 2033 · NDA 214846 · ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US 12,325,714, substance and product patent
patent.txt line 16,240
Flags
substance product
Product numbers
001
30 Sep 2033 · NDA 205934 · DOCETAXEL
US 8,940,786, product and use patent
patent.txt lines 6,041, 6,051, 6,061
Flags
product use code U-1789
Product numbers
001, 002, 003
30 Sep 2033 · NDA 205934 · DOCETAXEL
US 9,308,195, product patent
patent.txt lines 6,042, 6,052, 6,062
Flags
product
Product numbers
001, 002, 003
30 Sep 2033 · NDA 205934 · DOCETAXEL
US 9,763,880, use patent
patent.txt lines 6,043, 6,053, 6,063
Flags
use code U-2558
Product numbers
001, 002, 003
30 Sep 2033 · NDA 205934 · DOCETAXEL
US 9,763,880, use patent
patent.txt lines 6,044, 6,054, 6,064
Flags
use code U-2559
Product numbers
001, 002, 003
30 Sep 2033 · NDA 205934 · DOCETAXEL
US 9,763,880, use patent
patent.txt lines 6,045, 6,055, 6,065
Flags
use code U-2560
Product numbers
001, 002, 003
30 Sep 2033 · NDA 205934 · DOCETAXEL
US 9,763,880, use patent
patent.txt lines 6,046, 6,056, 6,066
Flags
use code U-2561
Product numbers
001, 002, 003
30 Sep 2033 · NDA 205934 · DOCETAXEL
US 9,763,880, use patent
patent.txt lines 6,047, 6,057, 6,067
Flags
use code U-2562
Product numbers
001, 002, 003
30 Sep 2033 · NDA 205934 · DOCETAXEL
US 9,763,880, use patent
patent.txt lines 6,048, 6,058, 6,068
Flags
use code U-2563
Product numbers
001, 002, 003
30 Sep 2033 · NDA 205934 · DOCETAXEL
US 9,763,880, use patent
patent.txt lines 6,049, 6,059, 6,069
Flags
use code U-2564
Product numbers
001, 002, 003
30 Sep 2033 · NDA 216993 · QUIZARTINIB DIHYDROCHLORIDE
US 9,675,549, product patent
patent.txt lines 19,135, 19,146
Flags
product
Product numbers
001, 002
4 Oct 2033 · NDA 214907 · PAFOLACIANINE SODIUM
US 9,254,341, substance and product patent
patent.txt line 16,321
Flags
substance product
Product numbers
001
6 Oct 2033 · NDA 206229 · LEVONORGESTREL
US 12,004,992, substance patent
patent.txt line 6,447
Flags
substance
Product numbers
001
6 Oct 2033 · NDA 213218 · TORSEMIDE
US 10,154,963, product patent
patent.txt lines 14,795–14,796
Flags
product
Product numbers
001, 002
7 Oct 2033 · NDA 214783 · BELUMOSUDIL MESYLATE
US 10,183,931, use patent
patent.txt line 16,114
Flags
use code U-3246
Product numbers
001
7 Oct 2033 · NDA 214783 · BELUMOSUDIL MESYLATE
US 10,183,931, use patent
patent.txt line 16,115
Flags
use code U-4260
Product numbers
001
7 Oct 2033 · NDA 214783 · BELUMOSUDIL MESYLATE
US 10,696,660, use patent
patent.txt line 16,116
Flags
use code U-3246
Product numbers
001
7 Oct 2033 · NDA 214783 · BELUMOSUDIL MESYLATE
US 10,696,660, use patent
patent.txt line 16,117
Flags
use code U-4260
Product numbers
001
8 Oct 2033 · NDA 205739 · PATIROMER SORBITEX CALCIUM
US 11,123,363, use patent
patent.txt lines 5,824, 5,831, 5,838, 5,845
Flags
use code U-1766
Product numbers
001, 002, 003, 004
8 Oct 2033 · NDA 205739 · PATIROMER SORBITEX CALCIUM
US 9,492,476, use patent
patent.txt lines 5,829, 5,836, 5,843, 5,850
Flags
use code U-1766
Product numbers
001, 002, 003, 004
8 Oct 2033 · NDA 205739 · PATIROMER SORBITEX CALCIUM
US 9,925,212, use patent
patent.txt lines 5,830, 5,837, 5,844, 5,851
Flags
use code U-1766
Product numbers
001, 002, 003, 004
12 Oct 2033 · NDA 220787 · CEFEPIME HYDROCHLORIDE; ZIDEBACTAM
US 9,657,021, substance patent
patent.txt line 22,391
Flags
substance
Product numbers
001
12 Oct 2033 · NDA 220787 · CEFEPIME HYDROCHLORIDE; ZIDEBACTAM
US 9,834,557, substance patent
patent.txt line 22,393
Flags
substance
Product numbers
001
15 Oct 2033 · NDA 207202 · ARIPIPRAZOLE
US 9,268,909, product and use patent
patent.txt lines 7,084, 7,111, 7,138, 7,165, 7,192, 7,219
Flags
product use code U-2168
Product numbers
001, 002, 003, 004, 005, 006
18 Oct 2033 · NDA 206619 · DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US 10,201,542, product and use patent
patent.txt line 6,600
Flags
product use code U-1753
Product numbers
001
18 Oct 2033 · NDA 206619 · DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US 9,629,841, product and use patent
patent.txt line 6,614
Flags
product use code U-1753
Product numbers
001
18 Oct 2033 · NDA 210498 · BINIMETINIB
US 9,562,016, substance and product patent
patent.txt line 11,555
Flags
substance product
Product numbers
001
18 Oct 2033 · NDA 210498 · BINIMETINIB
US 9,598,376, use patent
patent.txt line 11,556
Flags
use code U-2330
Product numbers
001
18 Oct 2033 · NDA 210498 · BINIMETINIB
US 9,980,944, use patent
patent.txt line 11,558
Flags
use code U-2334
Product numbers
001
18 Oct 2033 · NDA 218201 · COPPER
US 12,138,199, product patent
patent.txt line 20,900
Flags
product
Product numbers
001
21 Oct 2033 · NDA 209184 · LEVODOPA
US 12,458,615, use patent
patent.txt line 9,806
Flags
use code U-2484
Product numbers
001
22 Oct 2033 · NDA 207078 · SODIUM ZIRCONIUM CYCLOSILICATE
US 10,695,365, substance patent
patent.txt lines 7,013, 7,026
Flags
substance
Product numbers
001, 002
22 Oct 2033 · NDA 207078 · SODIUM ZIRCONIUM CYCLOSILICATE
US 8,877,255, substance patent
patent.txt lines 7,018, 7,031
Flags
substance
Product numbers
001, 002
22 Oct 2033 · NDA 207078 · SODIUM ZIRCONIUM CYCLOSILICATE
US 9,913,860, substance and use patent
patent.txt lines 7,022, 7,035
Flags
substance use code U-2312
Product numbers
001, 002
23 Oct 2033 · NDA 205388 · KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
US 9,066,856, product patent
patent.txt line 5,289
Flags
product
Product numbers
001
23 Oct 2033 · NDA 205388 · KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
US 9,486,406, product patent
patent.txt line 5,291
Flags
product
Product numbers
001
23 Oct 2033 · NDA 205388 · KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
US 9,855,246, product patent
patent.txt line 5,292
Flags
product
Product numbers
001
24 Oct 2033 · NDA 206229 · LEVONORGESTREL
US 11,090,186, use patent
patent.txt line 6,445
Flags
use code U-2348
Product numbers
001
24 Oct 2033 · NDA 207533 · ARIPIPRAZOLE LAUROXIL
US 9,193,685, product and use patent
patent.txt lines 7,289, 7,306, 7,324, 7,342
Flags
product use code U-543
Product numbers
001, 002, 003, 004
24 Oct 2033 · NDA 215401 · DEXTROAMPHETAMINE
US 9,456,993, product and use patent
patent.txt lines 16,871, 16,875, 16,879, 16,883
Flags
product use code U-3340
Product numbers
001, 002, 003, 004
24 Oct 2033 · NDA 215401 · DEXTROAMPHETAMINE
US 9,474,722, product patent
patent.txt lines 16,872, 16,876, 16,880, 16,884
Flags
product
Product numbers
001, 002, 003, 004
29 Oct 2033 · NDA 211855 · DIROXIMEL FUMARATE
US 8,669,281, substance and product patent
patent.txt line 13,218
Flags
substance product
Product numbers
001
30 Oct 2033 · NDA 205552 · IBRUTINIB
US 9,296,753, substance and product patent
patent.txt line 5,548
Flags
substance product
Product numbers
001
30 Oct 2033 · NDA 205552 · IBRUTINIB
US 9,296,753, substance patent
patent.txt line 5,646
Flags
substance
Product numbers
002
30 Oct 2033 · NDA 210563 · IBRUTINIB
US 9,296,753, substance patent
patent.txt lines 11,678, 11,782, 11,886, 11,995
Flags
substance
Product numbers
001, 002, 003, 004
30 Oct 2033 · NDA 217003 · IBRUTINIB
US 9,296,753, substance patent
patent.txt line 19,221
Flags
substance
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 10,206,891, use patent
patent.txt line 17,494
Flags
use code U-3641
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 10,265,281, use patent
patent.txt line 17,495
Flags
use code U-3639
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 10,842,762, use patent
patent.txt line 17,496
Flags
use code U-3640
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 11,026,899, use patent
patent.txt line 17,497
Flags
use code U-3639
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 11,026,900, use patent
patent.txt line 17,498
Flags
use code U-3639
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 11,026,901, use patent
patent.txt line 17,499
Flags
use code U-3638
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 11,944,594, use patent
patent.txt line 17,500
Flags
use code U-3864
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 11,944,595, use patent
patent.txt line 17,501
Flags
use code U-3867
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 11,944,595, use patent
patent.txt line 17,502
Flags
use code U-3868
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 12,233,035, use patent
patent.txt line 17,503
Flags
use code U-4132
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 12,280,025, use patent
patent.txt line 17,504
Flags
use code U-4168
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 12,364,675, use patent
patent.txt line 17,505
Flags
use code U-3639
Product numbers
001
1 Nov 2033 · NDA 215727 · COLCHICINE
US 9,744,144, use patent
patent.txt line 17,506
Flags
use code U-3643
Product numbers
001
4 Nov 2033 · NDA 206099 · SUMATRIPTAN SUCCINATE
US 10,478,574, use patent
patent.txt line 6,278
Flags
use code U-2404
Product numbers
001
5 Nov 2033 · NDA 210557 · BREMELANOTIDE ACETATE
US 10,286,034, use patent
patent.txt line 11,583
Flags
use code U-2568
Product numbers
001
5 Nov 2033 · NDA 210557 · BREMELANOTIDE ACETATE
US 9,352,013, use patent
patent.txt line 11,585
Flags
use code U-2568
Product numbers
001
5 Nov 2033 · NDA 210557 · BREMELANOTIDE ACETATE
US 9,700,592, use patent
patent.txt line 11,586
Flags
use code U-2568
Product numbers
001
7 Nov 2033 · NDA 214958 · DEUCRAVACITINIB
US 10,000,480, substance and product patent
patent.txt line 16,382
Flags
substance product
Product numbers
001
7 Nov 2033 · NDA 214958 · DEUCRAVACITINIB
US 11,021,475, use patent
patent.txt line 16,383
Flags
use code U-3434
Product numbers
001
7 Nov 2033 · NDA 214958 · DEUCRAVACITINIB
US RE47929, substance and product and use patent
patent.txt line 16,388
Flags
substance product use code U-3434
Product numbers
001
7 Nov 2033 · NDA 214958 · DEUCRAVACITINIB
US RE47929, substance and product and use patent
patent.txt line 16,389
Flags
substance product use code U-4452
Product numbers
001
8 Nov 2033 · NDA 211950 · TRIAMCINOLONE ACETONIDE
US 9,636,332, use patent
patent.txt line 13,248
Flags
use code U-3234
Product numbers
001
11 Nov 2033 · NDA 203168 · BROMFENAC SODIUM
US 9,517,220, use patent
patent.txt line 3,650
Flags
use code U-1933
Product numbers
001
14 Nov 2033 · NDA 203510 · PHENYLEPHRINE HYDROCHLORIDE
US 8,859,623, use patent
patent.txt lines 3,995–3,996
Flags
use code U-1594
Product numbers
001, 002
14 Nov 2033 · NDA 209445 · CEFIDEROCOL SULFATE TOSYLATE
US 9,238,657, substance and product and use patent
patent.txt line 10,381
Flags
substance product use code U-282
Product numbers
001
14 Nov 2033 · NDA 209445 · CEFIDEROCOL SULFATE TOSYLATE
US 9,238,657, substance and product and use patent
patent.txt line 10,382
Flags
substance product use code U-3470
Product numbers
001
14 Nov 2033 · NDA 209445 · CEFIDEROCOL SULFATE TOSYLATE
US 9,238,657, substance and product and use patent
patent.txt line 10,383
Flags
substance product use code U-3471
Product numbers
001
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 10,874,616, product patent
patent.txt lines 19,293, 19,346, 19,399, 19,452, 19,505
Flags
product
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,864, use patent
patent.txt lines 19,302, 19,355, 19,408, 19,461, 19,514
Flags
use code U-3226
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,864, use patent
patent.txt lines 19,303, 19,356, 19,409, 19,462, 19,515
Flags
use code U-3227
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,864, use patent
patent.txt lines 19,304, 19,357, 19,410, 19,463, 19,516
Flags
use code U-3228
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,864, use patent
patent.txt lines 19,305, 19,358, 19,411, 19,464, 19,517
Flags
use code U-3230
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,865, product and use patent
patent.txt lines 19,307, 19,360, 19,413, 19,466, 19,519
Flags
product use code U-3226
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,865, product and use patent
patent.txt lines 19,308, 19,361, 19,414, 19,467, 19,520
Flags
product use code U-3227
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,865, product and use patent
patent.txt lines 19,309, 19,362, 19,415, 19,468, 19,521
Flags
product use code U-3228
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,576,865, product and use patent
patent.txt lines 19,310, 19,363, 19,416, 19,469, 19,522
Flags
product use code U-3230
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,896,717, product and use patent
patent.txt lines 19,314, 19,367, 19,420, 19,473, 19,526
Flags
product use code U-3226
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,896,717, product and use patent
patent.txt lines 19,315, 19,368, 19,421, 19,474, 19,527
Flags
product use code U-3227
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,896,717, product and use patent
patent.txt lines 19,316, 19,369, 19,422, 19,475, 19,528
Flags
product use code U-3228
Product numbers
001, 002, 003, 004, 005
14 Nov 2033 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,896,717, product and use patent
patent.txt lines 19,317, 19,370, 19,423, 19,476, 19,529
Flags
product use code U-3230
Product numbers
001, 002, 003, 004, 005
15 Nov 2033 · NDA 215014 · PEGCETACOPLAN
US 10,035,822, substance patent
patent.txt line 16,417
Flags
substance
Product numbers
001
15 Nov 2033 · NDA 215014 · PEGCETACOPLAN
US 10,875,893, substance and use patent
patent.txt line 16,419
Flags
substance use code U-3124
Product numbers
001
15 Nov 2033 · NDA 215014 · PEGCETACOPLAN
US 10,875,893, substance and use patent
patent.txt line 16,420
Flags
substance use code U-4242
Product numbers
001
15 Nov 2033 · NDA 215014 · PEGCETACOPLAN
US 11,292,815, substance and product and use patent
patent.txt line 16,425
Flags
substance product use code U-3124
Product numbers
001
15 Nov 2033 · NDA 215014 · PEGCETACOPLAN
US 11,292,815, substance and product and use patent
patent.txt line 16,426
Flags
substance product use code U-3354
Product numbers
001
15 Nov 2033 · NDA 215014 · PEGCETACOPLAN
US 11,292,815, substance and product and use patent
patent.txt line 16,427
Flags
substance product use code U-4242
Product numbers
001
15 Nov 2033 · NDA 215014 · PEGCETACOPLAN
US 11,292,815, substance and product and use patent
patent.txt line 16,428
Flags
substance product use code U-4243
Product numbers
001
15 Nov 2033 · NDA 217171 · PEGCETACOPLAN
US 10,035,822, substance patent
patent.txt line 19,273
Flags
substance
Product numbers
001
15 Nov 2033 · NDA 217171 · PEGCETACOPLAN
US 10,875,893, substance and use patent
patent.txt line 19,275
Flags
substance use code U-3540
Product numbers
001
15 Nov 2033 · NDA 217171 · PEGCETACOPLAN
US 11,292,815, substance and product and use patent
patent.txt line 19,276
Flags
substance product use code U-3540
Product numbers
001
18 Nov 2033 · NDA 207154 · DAPSONE
US 11,273,132, product patent
patent.txt line 7,054
Flags
product
Product numbers
001
21 Nov 2033 · NDA 206307 · FINAFLOXACIN
US 9,504,691, product and use patent
patent.txt line 6,461
Flags
product use code U-1679
Product numbers
001
25 Nov 2033 · NDA 022408 · SPINOSAD
US 9,895,388, use patent
patent.txt line 1,798
Flags
use code U-3365
Product numbers
001
25 Nov 2033 · NDA 213137 · VOXELOTOR
US 9,018,210, substance and product patent
patent.txt lines 14,675, 14,688
Flags
substance product
Product numbers
001, 002
25 Nov 2033 · NDA 216157 · VOXELOTOR
US 9,018,210, substance and product patent
patent.txt line 18,373
Flags
substance product
Product numbers
001
27 Nov 2033 · NDA 211371 · BREXANOLONE
US 10,251,894, use patent
patent.txt line 12,857
Flags
use code U-2552
Product numbers
001
30 Nov 2033 · NDA 205437 · APREMILAST
US 12,576,034, product and use patent
patent.txt lines 5,401, 5,413, 5,425
Flags
product use code U-1858
Product numbers
001, 002, 003
30 Nov 2033 · NDA 205437 · APREMILAST
US 12,576,034, product and use patent
patent.txt lines 5,402, 5,414, 5,426
Flags
product use code U-4290
Product numbers
001, 002, 003
30 Nov 2033 · NDA 205437 · APREMILAST
US 12,576,034, product and use patent
patent.txt lines 5,403, 5,415, 5,427
Flags
product use code U-4291
Product numbers
001, 002, 003
30 Nov 2033 · NDA 212194 · GIVOSIRAN SODIUM
US 9,133,461, substance and product and use patent
patent.txt line 13,620
Flags
substance product use code U-2672
Product numbers
001
11 Dec 2033 · NDA 208791 · CHLOROPROCAINE HYDROCHLORIDE
US 9,504,666, product patent
patent.txt line 9,457
Flags
product
Product numbers
001
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,895, use patent
patent.txt lines 3,875, 3,892, 3,909, 3,926
Flags
use code U-1700
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,895, use patent
patent.txt lines 3,876, 3,893, 3,910, 3,927
Flags
use code U-1701
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,895, use patent
patent.txt lines 3,877, 3,894, 3,911, 3,928
Flags
use code U-1948
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,897, substance and use patent
patent.txt lines 3,878, 3,895, 3,912, 3,929
Flags
substance use code U-1700
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,897, substance and use patent
patent.txt lines 3,879, 3,896, 3,913, 3,930
Flags
substance use code U-1701
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,192,897, substance and use patent
patent.txt lines 3,880, 3,897, 3,914, 3,931
Flags
substance use code U-1948
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,384,086, substance and product and use patent
patent.txt lines 3,881, 3,898, 3,915, 3,932
Flags
substance product use code U-1700
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,384,086, substance and product and use patent
patent.txt lines 3,882, 3,899, 3,916, 3,933
Flags
substance product use code U-1701
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 11,384,086, substance and product and use patent
patent.txt lines 3,883, 3,900, 3,917, 3,934
Flags
substance product use code U-1948
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 9,493,470, substance and product and use patent
patent.txt lines 3,890, 3,907, 3,924, 3,941
Flags
substance product use code U-1700
Product numbers
001, 002, 003, 004
12 Dec 2033 · NDA 203469 · PONATINIB HYDROCHLORIDE
US 9,493,470, substance and product and use patent
patent.txt lines 3,891, 3,908, 3,925, 3,942
Flags
substance product use code U-1948
Product numbers
001, 002, 003, 004
16 Dec 2033 · NDA 210858 · SILDENAFIL CITRATE
US 11,123,287, product patent
patent.txt lines 12,215–12,218
Flags
product
Product numbers
001, 002, 003, 004
18 Dec 2033 · NDA 208073 · LIFITEGRAST
US 11,058,677, product patent
patent.txt line 8,083
Flags
product
Product numbers
001
19 Dec 2033 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,216,996, substance and product patent
patent.txt lines 11,217, 11,226
Flags
substance product
Product numbers
001, 002
19 Dec 2033 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,732,092, substance and product patent
patent.txt lines 11,221, 11,230
Flags
substance product
Product numbers
001, 002
19 Dec 2033 · NDA 221104 · BICTEGRAVIR SODIUM; LENACAPAVIR SODIUM
US 9,216,996, substance and product patent
patent.txt line 22,425
Flags
substance product
Product numbers
001
19 Dec 2033 · NDA 221104 · BICTEGRAVIR SODIUM; LENACAPAVIR SODIUM
US 9,732,092, substance and product patent
patent.txt line 22,427
Flags
substance product
Product numbers
001
19 Dec 2033 · NDA 221443 · BICTEGRAVIR SODIUM, LENACAPAVIR SODIUM; LENACAPAVIR SODIUM
US 9,216,996, substance and product patent
patent.txt line 22,435
Flags
substance product
Product numbers
001
19 Dec 2033 · NDA 221443 · BICTEGRAVIR SODIUM, LENACAPAVIR SODIUM; LENACAPAVIR SODIUM
US 9,732,092, substance and product patent
patent.txt line 22,437
Flags
substance product
Product numbers
001
23 Dec 2033 · NDA 211765 · UBROGEPANT
US 8,912,210, substance and product patent
patent.txt lines 13,168, 13,180
Flags
substance product
Product numbers
001, 002
24 Dec 2033 · NDA 216660 · SODIUM PHENYLBUTYRATE; TAURURSODIOL
US 10,251,896, use patent
patent.txt line 18,890
Flags
use code U-3460
Product numbers
001
24 Dec 2033 · NDA 216660 · SODIUM PHENYLBUTYRATE; TAURURSODIOL
US 10,857,162, use patent
patent.txt line 18,891
Flags
use code U-3460
Product numbers
001
24 Dec 2033 · NDA 216660 · SODIUM PHENYLBUTYRATE; TAURURSODIOL
US 11,071,742, product patent
patent.txt line 18,892
Flags
product
Product numbers
001
24 Dec 2033 · NDA 216660 · SODIUM PHENYLBUTYRATE; TAURURSODIOL
US 9,872,865, use patent
patent.txt line 18,894
Flags
use code U-3460
Product numbers
001

Pediatric exclusivity, as listed (45)

27 Aug 2033 · NDA 202714 · CARFILZOMIB
US 9,493,582 with pediatric exclusivity, as listed
patent.txt lines 3,142, 3,152, 3,162
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 10,272,046 with pediatric exclusivity, as listed
patent.txt lines 7,491, 7,524, 7,557, 7,590, 7,618
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 11,147,770 with pediatric exclusivity, as listed
patent.txt lines 7,495, 7,528, 7,561, 7,594, 7,622
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 11,752,106 with pediatric exclusivity, as listed
patent.txt lines 7,499, 7,532, 7,565, 7,598, 7,626
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 12,214,083 with pediatric exclusivity, as listed
patent.txt lines 7,501, 7,534, 7,567, 7,600, 7,628
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
27 Aug 2033 · NDA 207925 · IVACAFTOR
US 8,883,206 with pediatric exclusivity, as listed
patent.txt lines 7,519, 7,552, 7,585, 7,614, 7,642
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
6 Sep 2033 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,555,001 with pediatric exclusivity, as listed
patent.txt lines 7,988, 8,007
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 10,213,400 with pediatric exclusivity, as listed
patent.txt line 489
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 10,864,181 with pediatric exclusivity, as listed
patent.txt line 491
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 11,253,494 with pediatric exclusivity, as listed
patent.txt line 493
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 8,772,306 with pediatric exclusivity, as listed
patent.txt line 497
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 9,050,302 with pediatric exclusivity, as listed
patent.txt line 499
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 021196 · SODIUM OXYBATE
US 9,486,426 with pediatric exclusivity, as listed
patent.txt line 501
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,213,400 with pediatric exclusivity, as listed
patent.txt line 14,345
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 10,864,181 with pediatric exclusivity, as listed
patent.txt line 14,348
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 11,253,494 with pediatric exclusivity, as listed
patent.txt line 14,350
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 8,772,306 with pediatric exclusivity, as listed
patent.txt line 14,360
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,050,302 with pediatric exclusivity, as listed
patent.txt line 14,364
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
15 Sep 2033 · NDA 212690 · CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
US 9,486,426 with pediatric exclusivity, as listed
patent.txt line 14,367
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
22 Oct 2033 · NDA 204629 · EMPAGLIFLOZIN
US 12,527,810 with pediatric exclusivity, as listed
patent.txt lines 4,897, 4,928
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
22 Oct 2033 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,527,810 with pediatric exclusivity, as listed
patent.txt lines 6,312, 6,343, 6,372, 6,401
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 10,478,441 with pediatric exclusivity, as listed
patent.txt line 13,551
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 10,478,442 with pediatric exclusivity, as listed
patent.txt line 13,553
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 12,097,206 with pediatric exclusivity, as listed
patent.txt line 13,570
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,549,909 with pediatric exclusivity, as listed
patent.txt line 13,572
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,603,814 with pediatric exclusivity, as listed
patent.txt line 13,574
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,603,815 with pediatric exclusivity, as listed
patent.txt line 13,576
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Nov 2033 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE
US 9,610,260 with pediatric exclusivity, as listed
patent.txt line 13,578
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,106,548 with pediatric exclusivity, as listed
patent.txt lines 5,474, 5,573
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,125,140 with pediatric exclusivity, as listed
patent.txt lines 5,476, 5,575
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,294,231 with pediatric exclusivity, as listed
patent.txt lines 5,478, 5,577
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,294,232 with pediatric exclusivity, as listed
patent.txt lines 5,480, 5,579
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,752,634 with pediatric exclusivity, as listed
patent.txt line 5,499
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 10,961,251 with pediatric exclusivity, as listed
patent.txt lines 5,501, 5,598
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 9,713,617 with pediatric exclusivity, as listed
patent.txt lines 5,553, 5,651
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 205552 · IBRUTINIB
US 9,725,455 with pediatric exclusivity, as listed
patent.txt lines 5,555, 5,653
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 10,106,548 with pediatric exclusivity, as listed
patent.txt lines 11,596, 11,702, 11,806, 11,910
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 10,125,140 with pediatric exclusivity, as listed
patent.txt lines 11,598, 11,704, 11,808, 11,912
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 10,752,634 with pediatric exclusivity, as listed
patent.txt line 11,619
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 10,961,251 with pediatric exclusivity, as listed
patent.txt lines 11,623, 11,727, 11,831, 11,938
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2033 · NDA 210563 · IBRUTINIB
US 9,725,455 with pediatric exclusivity, as listed
patent.txt lines 11,681, 11,785, 11,889, 11,998
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2033 · NDA 217003 · IBRUTINIB
US 10,106,548 with pediatric exclusivity, as listed
patent.txt line 19,152
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Dec 2033 · NDA 217003 · IBRUTINIB
US 10,125,140 with pediatric exclusivity, as listed
patent.txt line 19,154
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Dec 2033 · NDA 217003 · IBRUTINIB
US 10,961,251 with pediatric exclusivity, as listed
patent.txt line 19,170
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Dec 2033 · NDA 217003 · IBRUTINIB
US 9,725,455 with pediatric exclusivity, as listed
patent.txt line 19,222
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001

Non-patent exclusivity (3)

26 Sep 2033 · NDA 217628 · CLOTRIMAZOLE
GAIN exclusivity
exclusivity.txt line 1,894
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001
22 Oct 2033 · NDA 212271 · FOSFOMYCIN DISODIUM
GAIN exclusivity
exclusivity.txt line 1,032
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001
15 Nov 2033 · NDA 214520 · HEPARIN SODIUM; TAUROLIDINE
GAIN exclusivity
exclusivity.txt lines 1,339, 1,341
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001, 002